rTMS and Theta Burst Stimulation in Late-Life Depression: Suicidal Ideation Findings from the FOUR-D Trial
For healthcare professionals only. Educational use. TMS is not approved for treating suicidal ideation. Late-life depression remains a significant clinical challenge and is closely associated with suicidal ideation, particularly in patients with treatment-resistant depression. While Transcranial Magnetic Stimulation (TMS) has been studied in major depressive disorder, data focused specifically on older adults have been more […]
Transcranial Magnetic Stimulation (TMS) for PTSD: Insights from a Multisite Real-World Cohort
Posttraumatic stress disorder (PTSD) remains a complex and often persistent condition, particularly among military Veterans, where symptom burden may continue despite psychotherapy and pharmacological interventions. In this context, transcranial magnetic stimulation (TMS), a non-invasive neuromodulation technique, is increasingly being explored in clinical research, although it is not currently approved for the treatment of PTSD. A […]
Theta Burst Stimulation (TBS) for Auditory Hallucinations in Schizophrenia: Findings from a Phase 3 Trial
This content is intended for healthcare professionals and is provided for educational purposes only. Transcranial magnetic stimulation (TMS) is not approved for the treatment of auditory hallucinations in schizophrenia. TMS is not approved for treating suicidal ideation. Auditory verbal hallucinations are among the most disabling symptoms associated with schizophrenia spectrum disorders, with many individuals continuing […]
White Matter Connectivity and iTBS Response in Depression: Insights from a 2025 Study
This content is intended for healthcare professionals and is provided for educational purposes only. Intermittent theta burst stimulation (iTBS), a form of Transcranial Magnetic Stimulation (TMS), has been shown to produce antidepressant effects in patients with major depressive disorder. However, clinical response to iTBS varies across individuals, and the biological factors underlying this variability remain […]
Repetitive Transcranial Magnetic Stimulation for Central Neuropathic Pain: “Superficial” vs “deep” rTMS in a Randomized Trial
This content is intended for healthcare professionals and is provided for educational purposes only. Transcranial magnetic stimulation (TMS) is not broadly approved for the treatment of central neuropathic pain. Central neuropathic pain remains a significant clinical challenge, with many patients experiencing limited relief despite long-term pharmacological treatment. In parallel, increasing attention has been directed toward […]
Intermittent Theta Burst Stimulation (iTBS) for Alcohol Use Disorder: Effects on Relapse and Drinking Outcomes
This content is intended for healthcare professionals and is provided for educational purposes only. Transcranial magnetic stimulation (TMS) is not approved for the treatment of alcohol use disorder. Alcohol use disorder (AUD) remains associated with high relapse rates, with many individuals returning to hazardous drinking levels within months of treatment. This highlights the need for […]
Accelerated vs Conventional rTMS for Treatment-Resistant Depression: Insights from a 5×5 Protocol Study
This content is intended for healthcare professionals and is provided for educational purposes only. Transcranial Magnetic Stimulation (TMS) is an established, FDA-cleared treatment for major depressive disorder, including in patients with treatment-resistant depression. Advances in neuromodulation protocols, such as intermittent theta burst stimulation, have reduced session duration and improved treatment efficiency. Building on this, accelerated […]